We recently published a list of the 10 Best Low Priced Stocks to Invest in Now. In this article, we are going to take a look ...

Scotiabank analyst Orest Wowkodaw raised the firm’s price target on NexGen Energy (NXE) to C$14.50 from C$14 and keeps an Outperform rating on ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.55% of ...

Director Leigh Robert Curyer purchased 1,500,000 shares of the business’s stock in a transaction on Friday, December 20th. The stock was acquired at an average price of C$10.05 per share, for a total ...

NexGen Energy Ltd. ("NexGen" or the "Company") (TSX: NXE) (NYSE: NXE) (ASX: NXG) is pleased to announce it has been awarded the first uranium sales agreements with multiple leading US nuclear ...

NXE-0048149 is under clinical development by Nxera Pharma and currently in Phase I for Psychosis. According to GlobalData, Phase I drugs for Psychosis have a 59% phase transition success rate (PTSR) ...

Detailed price information for Nexgen Energy Ltd (NXE-T) from The Globe and Mail including charting and trades.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...